Phibro Animal Health Corporation and Rejuvenate Bio Announce Agreement to Develop Gene Therapy for Mitral Valve Disease in Canines
Previous
Previous
Rejuvenate Bio Announces Team Expansion with Appointments of Garrett Berry and Sophia Gee
Next
Next